Finally, Someone JANUARY/FEBRUARY 2014 - VOLUME 39 ISSUE 1
Cleaned up Purifi cation Waters’ robust purifi cation solutions are fl exible, scalable, and easily integrated. From high-throughput fraction collection of hundreds of samples, to purifying just a handful of samples a day, Waters enhances the speed and reliability of your lab’s workfl ow.
1454ad@reply-direct.com
Discover the signifi cant benefi ts of having multiple Waters instruments in your lab. Each of our three techniques for purifying samples (SFE, SFC, and LC) can complement the others, and this orthogonal perspective gained by purifying with more than one technique allows for greater ability to discover and identify compounds in a sample.
It’s easy to take a process that’s so common for granted – but we don’t. Discover more at
www.waters.com/prep.
OFC_ILM_FEB_14.indd 1 07/02/2014 13:31 Mass Spectrometry & Spectroscopy
1454ad@reply-direct.com
Enhancing Mass Spectrometric Performance with Field Asymmetric Waveform Ion Mobility Spectrometry
Robert W. Smith, Lauren Brown, Danielle Toutoungi, James C. Reynolds, Billy Boyle, Colin S. Creaser
14 Laboratory Products Head Office - International Labmate Ltd
Oak Court, Sandridge Park, St AIbans, Hertfordshire AL3 6PH, United Kingdom. Tel: +44 (0)1727 855574 • Fax: +44 (0)1727 841694 Amend your subscription:
subscribe@intlabmate.com Other enquiries:
info@intlabmate.com •
sales@intlabmate.com ISSN 0143-5140
Publishers of: International Labmate, Labmate UK & Ireland, Lab Asia, Chromatography Today, International Environmental Technology, Asian Environmental Technology, Pollution Solutions, Petro Industry News and Measurement Analysis China
Publisher Michael H. Pattison
Director of Publications Marcus Pattison
michael@intlabmate.com
marcus@intlabmate.com
North American Area Manager Carol Hardy
Director, Asia Pacific Marie Izzard
carol@intlabmate.com
marie@intlabmate.com.au
Sales & Marketing Manager Chris Jarvis
European Sales Manager John Hobbs-Morris
Area Manager Carly Hider
Online Manager Rob Parker
Guide Manager Sam Jackson
Guide Assistant Joanna Hemmings
Reader Services Manager Sue Petts
chris@intlabmate.com
john@intlabmate.com
carly@intlabmate.com
rob@intlabmate.com
sam@intlabmate.com
joanna@intlabmate.com
sue@intlabmate.com
Editor Gwyneth Astles
Contributing Editor Heather Hobbs
Business Opportunities Heather Hobbs
gwyneth@intlabmate.com
heather@intlabmate.com
Contributing Editor - Separation Science Trevor Hopkins
Production Manager Robert Battell
Production Team Heather Vincent Jill Mitchell Caroline Belt
Finance Controller Chris Brown
Accounts Assistants Linda Hudson
Maureen Woodhouse
Credit Control Patricia Rogers
Subscriptions Manager Maureen Woodhouse
Market Research
trevor@intlabmate.com
robert@intlabmate.com
heatherv@intlabmate.com
jill@intlabmate.com
caroline@intlabmate.com
chris@labmate.net
linda@labmate.net
maureen@labmate.net
patricia@labmate.net
maureen@labmate.net Marstonbury Ltd
Show Previews
Printed by Warners Midlands Plc, Covers printed by Colt Press Ltd, Published by International Labmate Ltd
Published: January, February, April, May Buyers Guide, July, August, October
International Labmate is a member of the
following trade associations:
International Labmate is distributed to scientists, technologists, laboratory technicians and environmentalists throughout the Europe and Middle East, free of charge. The publication has the support of leading suppliers of equipment in the region and is displayed at the major exhibitions and conferences in these markets to attract additional readership.
Subscriptions: FOR ONE YEAR; Outside Europe or the Middle East - $100. Cheques made payable to International Labmate Ltd Alternatively fill in the Buying Now/User card and tick the subscription box
In order to obtain information on any of the products included in this journal, please fill in the appropriate numbers on the Reader Reply card and post or fax it to us. Alternatively contact the company directly by email, phone or via the website.
Buying Now Scientific Instruments Survey: Should you use or be planning to buy scientific apparatus and would like to receive the latest available information, please return the appropriate card.
North American Office: Carol Hardy - International Labmate Ltd 333 Colony Blvd. #194 The Villages, FL 32162, United States Tel: +(1) 623-869-0184 Fax: +(1) 623-321-9200. E-mail:
carol@intlabmate.com
Asian Office: Marie Izzard - International Labmate Ltd PO Box 374, Mona Vale, NSW, 1660, Australia Tel: +61 (0) 2 9918 0317 Fax: +61 (0) 2 9918 0316 E-mail:
marie@intlabmate.com.au
Japan: Mr Koichi Ogawa - OTO Research Corporation Takeuchi Building 1 -34-12 Takatanobaba, Shinjuku-Ku, Tokyo 169, Japan Tel: (03) 3208 7821 Fax: (03) 3200 2889
Korea: Pearl Yoon-Joo Jin - The Peak Media Co Ltd Suite B-2010, Intellige 2 B/D, 24 Jeongja-dong, Bundang-gu, Seongnam, Gyunggi-do 463-841, Republic of Korea Tel: +82 (0)70 4639 3008 Fax: +82 (0)31 712 3228 Email:
pearl@tpmkr.com
International Labmate is published six times per annum in tabloid format. In addition a most comprehensive “Guide to Laboratory and Environmental Equipment” printed in A4 format. It incorporates companies, products and dealers, mailed in May/June.
Although every effort is made to ensure the accuracy of material published, International Labmate and its offices cannot accept responsibility for claims made by contributors, manufacturers or advertisers.
© All rights reserved by International Labmate Ltd. Reproduction in part or whole without written permission is strictly prohibited. Please look after the environment by recycling this magazine Also available at:
labmate-online.com/ejournal/
Sample Preparation & Processing Gwyneth Astles
76 Special Features
Food Beverage Analysis Gwyneth Astles
24
Pumps, Valves & Liquid Handling Gwyneth Astles
48
Pittcon Show Preview Gwyneth Astles
34
Arablab Show Preview Gwyneth Astles
60 Microscopy & Microtechniques
Cindy Chen, Terry Gaige, Ivana Zubonja, Paul Hung
84-89 New Method for Real-Time Autophagy Studies 84
DNA Technology: 150 Years of Research and Development
Tracy Alexander BA(Hons) 74 82
Research & Events News Heather Hobbs
2
News & Views Heather Hobbs
22 2-83 14-21
In this Issue Chromatography
CaptureSMB for Effi cient Affi nity Purifi cation of Monoclonal Antibodies
Thomas Müller-Späth, Monica Angarita, Daniel Baur, Roel Lievrouw, Geert Lissens, Guido Ströhlein, Michael Bavand, Massimo Morbidelli
4
4-13
With expansion a prime focus for businesses worldwide, many are looking towards rapidly establishing new regions of growth, particularly in Asia, Pacific Rim countries.
This section of International Labmate will especially look at the success of both Asian and European companies with established premises or business partnerships, highlighting the opportunities that exist while realising potential for other companies to move into export markets.
ASIA
by Heather Hobbs To appear in our next issue, send your Business and Financial News stories to
heather@intlabmate.com
Business
Opportunities
ILM - Business Opps Asia:N&V 31/10/13 15:30 Page 1
Agilent Technologies Receive Recognition Award
Agilent Technologies announced it has been named Frost & Sullivan’s 2013 Laboratory Analytical Instrumentation Company of the Year in China, based on the findings of its Best Practices Research. The company was recognised for demonstrating consistent excellence in growth strategy and implementation, technological innovation, customer value and market penetration in the Chinese laboratory analytical instrumentation industry.
“China’s analytical instrumentation industry is becoming more and more competitive, with increased demand from the food, environmental, pharmaceutical, academic and government research markets,” said Leo Jia, Industry Analyst for Frost & Sullivan. “Our research shows that Agilent continues to perform well and has maintained its position as the industry leader in China for several years, and we expect it to dominate the market throughout the forecast period with its strong position in the GC, HPLC, and MS market segments.”
As the company’s global hub for laboratory instrument research and development, Agilent China is also home to 21 local offices, four manufacturing facilities and four customer- training centres. Operations are managed by a team of 1,800 employees who provide customised products and services to government, university and industry laboratories.
“Having served laboratory researchers and scientists in China for more than 30 years, we are very pleased to earn this award as it reflects upon the strength of our team in China and our commitment to customers,” said Mike McMullen, President of Agilent’s Chemical Analysis Group.
“China has always been a critical market for our life sciences group and we will continue to invest in infrastructure and people to further optimise our product portfolio to provide customers with the best analytical solutions,” said Nick Roelofs, President of Agilent’s Life Sciences Group.
More Info. 180
Immutep and Eddingpharm Sign Agreement for Development of Cancer Therapies
Immutep SA, a biopharmaceutical company specialising in immuno-oncology, and Eddingpharm have entered into an agreement regarding the development, commercialisation and manufacturing of Immutep’s ImmuFact®
presentation to T cells. IMP321 (a first-in-class APC activator) can be used in combination with first-line chemotherapy or in combination with checkpoint inhibitors.
IMP321. Financial details
were undisclosed but include milestone payments and royalties. Burrill Securities acted as financial advisor on this transaction.
The agreement grants Eddingpharm rights to develop and market IMP321 in mainland China, Hong Kong, Macau and Taiwan. Immutep will provide full technical support for the development of the product. Immutep and Eddingpharm plan to develop the product for first-line metastatic breast cancer as well as other first-line metastatic indications.
Like the checkpoint inhibitors that induce tumor regression and extend survival, antigen presenting cell (APC) activators increase the T cell response against tumours by a different but complementary mechanism, which enhances antigen
"We have been very impressed by the dynamic and innovative approach of Eddingpharm, and believe them to have the capability of driving the development of IMP321 in China,” said John Hawken, CEO. “Immutep is continuing the development of IMP321 in Europe and the USA. We are in partnering discussions at present.”
“We are excited to be entering the new field of immuno- oncology. We believe that immuno-oncology will revolutionise cancer treatment," said Xin Ni, chairman and chief executive officer of Eddingpharm. "Our priority is bringing new and effective treatments to patients. We look forward to working closely with Immutep to develop IMP321 in first-line metastatic breast cancer as well as other first-line metastatic indications.”
More Info. 181 Distributor Contract Signals Titian’s Commitment to China
As part of its strategic investments programme to grow the global popularity of its Mosaic sample management product, Titian Software has recently granted exclusive distribution rights to LBD Life Sciences in China, to provide a more accessible support service for Chinese customers. Based in Shanghai, a dedicated Application Support Specialist with advanced technical and operational knowledge of Mosaic will be on-hand, providing new and existing users with a local contact for readily available help and expertise.
Titian continues its expansion in the Far East, and last year saw the integration of Mosaic software into three major Chinese research institutions and commercial R&D facilities, with further sites under discussion. The new distributorship agreement allows
LBD Life Sciences China to respond to the growing demand for an efficient sample management set-up, and explore further opportunities for Mosaic with Chinese customers.
Edmund Wilson, Titian’s CEO, said: “Mosaic has been designed to provide comprehensive and reliable sample management for sites worldwide. In the US and Europe it has been established as the de facto standard in sample management for several years and its increasing uptake in Asia - and especially China - is proof of its impact and suitability for global operations. We are keen to further expand the reach of Mosaic, and our new agreement with LBD Life Sciences will allow us to give our Chinese customers the same level of support as that enjoyed by our customers in other regions.”
More Info. 182
GE Healthcare Life Sciences is to provide a KUBio™ modular biopharmaceutical factory for JHL Biotech in China. Expected to be fully operational early 2015 the unit will be located at the Biolake Science Park in Wuhan.
KUBio provides customers with a fully functional, ready-to-run bioprocessing facility in 14-18 months, significantly shorter than construction of a traditional facility. Pre-designed to meet cGMP requirements, pre-made modules come equipped with technologies for the start-to-finish manufacture of biopharmaceuticals.
Members of GE’s experienced Shanghai Fast Trak team will also be deployed to validate the equipment and provide training for JHL Biotech staff. After completion, the JHL Biotech KUBio facility will have a floor space of approximately 2,400m2
and will contain a number of 2,000L single-use bioreactors.
Olivier Loeillot, General Manager of Enterprise Solutions, GE Healthcare Life Sciences (pictured), said, “The decision of JHL Biotech’s highly experienced team to select KUBio as the basis of its commercial cGMP biopharmaceutical manufacturing capabilities in China is a fantastic endorsement of our complete, turnkey approach. We look forward to working with them to bring the facility online to serve the fast-moving biopharmaceutical industry. A diverse range of customers, including governments and pharmaceutical companies, are continuing to recognise the breadth, depth, simplicity and flexibility of what we offer with KUBio.“
Racho Jordanov, Co-founder, President and CEO of JHL Biotech added, “In realising our vision of making world-class biopharmaceuticals affordable and accessible to all patients, KUBio was the natural choice. Utilising manufacturing innovations was always a key part of our strategy and GE Healthcare’s KUBio delivers the technologies we want, with the technical support and training we need.”
More Info. 183
Modular
Biopharmaceutical Factory for JHL Biotech
Does your company sell or wish to sell laboratory products and services to the economies of Asia? Are you looking for local distributors and agents to represent you?
If so, why not advertise your products in our market-leading journal International Labmate. Contact us today for more information:
info@intlabmate.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96
